Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT02462265
What this trial is testing

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaLymphoid Leukemia
Oshadi Drug Administration 15
Early research (Phase 1)Ended earlyNCT01957644
What this trial is testing

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Boehringer Ingelheim 16
Early research (Phase 1)Ended earlyNCT00100971
What this trial is testing

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Boston Medical Center 9
Not applicableLooking for participantsNCT06891144
What this trial is testing

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

Who this might be right for
AML, Adult
French Innovative Leukemia Organisation 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03603964
What this trial is testing

Guadecitabine Extension Study

Who this might be right for
Acute Myeloid LeukemiaMyeloid Dysplastic Syndrome
Astex Pharmaceuticals, Inc. 35
Early research (Phase 1)Not Yet RecruitingNCT06252584
What this trial is testing

Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia, Adult
University Hospital Tuebingen 20
Early research (Phase 1)Study completedNCT00270452
What this trial is testing

Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI) 9
Early research (Phase 1)Looking for participantsNCT07107126
What this trial is testing

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Remedy Plan, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00004255
What this trial is testing

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Chimeric Therapies
Early research (Phase 1)Study completedNCT01137747
What this trial is testing

Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04065399
What this trial is testing

Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Lineage Acute Leukemia+2 more
Syndax Pharmaceuticals 447
Not applicableUnknownNCT03659084
What this trial is testing

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Hospices Civils de Lyon 150
Not applicableNot Yet RecruitingNCT06758726
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT02461121
What this trial is testing

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Testing effectiveness (Phase 2)Study completedNCT00241358
What this trial is testing

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more
Washington University School of Medicine 92
Not applicableLooking for participantsNCT01311258
What this trial is testing

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
University of Rochester 400
Early research (Phase 1)Ended earlyNCT00887926
What this trial is testing

Study of IMC-EB10 in Participant With Leukemia

Who this might be right for
Myeloid Leukemia
Eli Lilly and Company 25
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Ended earlyNCT01743807
What this trial is testing

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Who this might be right for
Relapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 4
Next Page